Today’s Infectious Disease News (11/26/22)

Screen Shot 2023-04-01 at 9.09.36 AM

Split-Dosing of COVID-19 Vaccines is No Different than Normal Dose in Terms of Effectiveness or Safety

A new study finds that split dosing of the COVID-19 vaccine, due to patient concerns about allergies, is not inferior in terms of safety or effectiveness. While anaphylactic (severe) reactions from the vaccine are extremely rare, up to 2% of people receiving the vaccine have experienced mild allergic reactions or sensitivities. The study was one of the first to investigate the safety and effectiveness of split-dosing. The encouraging results may provide an alternative way for people with allergy concerns to get vaccinated against COVID-19. The researchers explained, “The split vaccine dosing-induced increase in receptor binding domain and spike protein 1 antibody expression is noninferior to [that with] conventional dosing”.

Full Story: DG News